Supplementary Table S2 from Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table S2. Patient Demographics and Baseline Disease Characteristics.
Authors: Ahmad A. Tarhini, Alyssa Obermayer, Sandra J. Lee, William A. LaFramboise, F. Stephen Hodi, Arivarasan D. Karunamurthy, Islam Eljilany, Dung-Tsa Chen, Patrick Hwu, Issam M. El Naqa, Howard Streicher, Vernon K. Sondak, Walter J. Storkus, Lisa H. Butterfield, Timothy I. Shaw, John M. Kirkwood
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4412843647